Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VENUS: Validation of Septic Gene ExpressioN Using SeptiCyte®

NCT02127502 is registered in ClinicalTrials.gov with Immunexpress as lead sponsor.

NCT NCT02127502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02127502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VENUS: Validation of Septic Gene ExpressioN Using SeptiCyte®
Lead sponsor
Immunexpress
Phase
Observational
Overall status
Completed
Start date
April 30, 2014
Completion date
December 31, 2016
Enrollment
379 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, systemic inflammatory response syndrome (sirs)